See every side of every news story
Published loading...Updated

Arbutus expects to significantly reduce its net cash burn in 2025

Summary by The New York Ledger
Arbutus Biopharma ( NASDAQ: ABUS) revealed on Monday its 2025 business goals and supplied a monetary upgrade. The business had money, money equivalents and financial investments in valuable securities amounting to around $123 million since December 31, 2024. The business anticipates to considerably Source: Business Insider. The post Arbutus expects to significantly reduce its net cash burn in 2025 appeared first on The New York Ledger.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The New York Ledger broke the news in on Tuesday, January 14, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.